{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:09:09Z","timestamp":1791925749417,"version":"4.3.4"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100002261","name":"Russian Foundation for Basic Research","doi-asserted-by":"publisher","award":["13-04-40287-H"],"award-info":[{"award-number":["13-04-40287-H"]}],"id":[{"id":"10.13039\/501100002261","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Biochemistry and Biophysics"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.abb.2016.02.010","type":"journal-article","created":{"date-parts":[[2016,2,13]],"date-time":"2016-02-13T02:34:10Z","timestamp":1455330850000},"page":"60-68","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"special_numbering":"C","title":["Slow-binding inhibition of cholinesterases, pharmacological and toxicological relevance"],"prefix":"10.1016","volume":"593","author":[{"given":"Patrick","family":"Masson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofya V.","family":"Lushchekina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1\u20133","key":"10.1016\/j.abb.2016.02.010_bib1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.cbi.2008.05.035","article-title":"Acetylcholinesterase: how is structure related to function?","volume":"175","author":"Silman","year":"2008","journal-title":"Chem. Biol. Interact."},{"issue":"3","key":"10.1016\/j.abb.2016.02.010_bib2","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.coph.2005.01.014","article-title":"Acetylcholinesterase: \u2018classical\u2019 and \u2018non-classical\u2019 functions and pharmacology","volume":"5","author":"Silman","year":"2005","journal-title":"Curr. Opin. Pharmacol."},{"issue":"1","key":"10.1016\/j.abb.2016.02.010_bib3","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.cbi.2012.09.014","article-title":"Cholinesterases in development: AChE as a firewall to inhibit cell proliferation and support differentiation","volume":"203","author":"Layer","year":"2013","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.abb.2016.02.010_bib4","series-title":"Handbook of Toxicology of Chemical Warfare Agents","first-page":"1107","article-title":"Catalytic bioscavengers: the new generation of bioscavenger-based medical countermeasures","author":"Masson","year":"2015"},{"key":"10.1016\/j.abb.2016.02.010_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.ygcen.2015.05.017","article-title":"Pure human butyrylcholinesterase hydrolyzes octanoyl ghrelin to desacyl ghrelin","author":"Schopfer","year":"2015","journal-title":"Gen. Comp. Endocrinol."},{"key":"10.1016\/j.abb.2016.02.010_bib6","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.pharmthera.2014.11.011","article-title":"Review of human butyrylcholinesterase structure, function, genetic variants, history of use in the clinic, and potential therapeutic uses","volume":"148","author":"Lockridge","year":"2015","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.abb.2016.02.010_bib7","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1146\/annurev.bi.48.070179.002351","article-title":"Slow transitions and hysteretic behavior in enzymes","volume":"48","author":"Frieden","year":"1979","journal-title":"Annu. Rev. Biochem."},{"issue":"2","key":"10.1016\/j.abb.2016.02.010_bib8","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0022-5193(76)90059-X","article-title":"The theoretical analysis of kinetic behaviour of \u201chysteretic\u201d allosteric enzymes. I. The kinetic manifestations of slow conformational change of an oligomeric enzyme in the Monod, Wyman and Changeux model","volume":"60","author":"Kurganov","year":"1976","journal-title":"J.\u00a0Theor. Biol."},{"issue":"23","key":"10.1016\/j.abb.2016.02.010_bib9","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1016\/0006-2952(75)90050-7","article-title":"Tight-binding inhibitors-I. Kinetic behavior","volume":"24","author":"Cha","year":"1975","journal-title":"Biochem. Pharmacol."},{"issue":"3","key":"10.1016\/j.abb.2016.02.010_bib10","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/0968-0004(82)90157-8","article-title":"The slow-binding and slow, tight-binding inhibition of enzyme-catalysed reactions","volume":"7","author":"Morrison","year":"1982","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.abb.2016.02.010_bib11","first-page":"347","article-title":"Approaches to the study and analysis of the inhibition of enzymes by slow- and tight-binding inhibitors","volume":"2","author":"Morrison","year":"1985","journal-title":"Comments Mol. Cell. Biophys."},{"issue":"1","key":"10.1016\/j.abb.2016.02.010_bib12","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S0167-4838(96)00118-5","article-title":"Slow-binding inhibition: the general case","volume":"1298","author":"Sculley","year":"1996","journal-title":"Biochim. Biophys. Acta Protein Struct. Mol. Enzymol."},{"issue":"3","key":"10.1016\/j.abb.2016.02.010_bib13","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0303-2647(99)00053-2","article-title":"Kinetic analysis of enzyme reactions with slow-binding inhibition","volume":"51","author":"Garrido-del Solo","year":"1999","journal-title":"Biosystems"},{"key":"10.1016\/j.abb.2016.02.010_bib14","series-title":"Kinetics of Enzyme-modifier Interactions","author":"Baici","year":"2015"},{"key":"10.1016\/j.abb.2016.02.010_bib15","series-title":"Evaluation of Enzyme Inhibitors in Drug Discovery: a Guide for Medicinal Chemists and Pharmacologists","author":"Copeland","year":"2013"},{"issue":"6","key":"10.1016\/j.abb.2016.02.010_bib16","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.sbi.2005.10.017","article-title":"Enzymatic transition states and transition state analogues","volume":"15","author":"Schramm","year":"2005","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.abb.2016.02.010_bib17","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/0076-6879(95)49034-5","article-title":"Kinetics of slow and tight-binding inhibitors","volume":"249","author":"Szedlacsek","year":"1995","journal-title":"Methods Enzymol."},{"issue":"33","key":"10.1016\/j.abb.2016.02.010_bib18","doi-asserted-by":"crossref","first-page":"13737","DOI":"10.1073\/pnas.0907195106","article-title":"Conformational selection or induced fit: a flux description of reaction mechanism","volume":"106","author":"Hammes","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.abb.2016.02.010_bib19","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.bpc.2014.03.003","article-title":"Distinguishing induced fit from conformational selection","volume":"189","author":"Gianni","year":"2014","journal-title":"Biophys. Chem."},{"key":"10.1016\/j.abb.2016.02.010_bib20","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S0076-6879(80)64010-5","article-title":"Hysteretic enzymes","volume":"64","author":"Neet","year":"1980","journal-title":"Methods Enzymol."},{"issue":"9","key":"10.1016\/j.abb.2016.02.010_bib21","doi-asserted-by":"crossref","first-page":"e24545","DOI":"10.1371\/journal.pone.0024545","article-title":"Hysteretic behavior of proprotein convertase 1\/3 (PC1\/3)","volume":"6","author":"Icimoto","year":"2011","journal-title":"PLoS One"},{"issue":"20","key":"10.1016\/j.abb.2016.02.010_bib22","doi-asserted-by":"crossref","first-page":"5481","DOI":"10.1021\/bi8002023","article-title":"Residence time of receptor-ligand complexes and its effect on biological function","volume":"47","author":"Tummino","year":"2008","journal-title":"Biochemistry"},{"issue":"4","key":"10.1016\/j.abb.2016.02.010_bib23","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1517\/17460441003677725","article-title":"The dynamics of drug-target interactions: drug-target residence time and its impact on efficacy and safety","volume":"5","author":"Copeland","year":"2010","journal-title":"Expert Opin. Drug Discov."},{"issue":"12","key":"10.1016\/j.abb.2016.02.010_bib24","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.4155\/fmc.11.112","article-title":"Conformational adaptation in drug-target interactions and residence time","volume":"3","author":"Copeland","year":"2011","journal-title":"Future Med. Chem."},{"issue":"3","key":"10.1016\/j.abb.2016.02.010_bib25","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0026-895X(25)10030-8","article-title":"Role of tyrosine 337 in the binding of huperzine A to the active site of human acetylcholinesterase","volume":"45","author":"Ashani","year":"1994","journal-title":"Mol. Pharmacol."},{"issue":"37","key":"10.1016\/j.abb.2016.02.010_bib26","doi-asserted-by":"crossref","first-page":"11340","DOI":"10.1021\/ja029775t","article-title":"How does huperzine A enter and leave the binding gorge of acetylcholinesterase? Steered molecular dynamics simulations","volume":"125","author":"Xu","year":"2003","journal-title":"J.\u00a0Am. Chem. Soc."},{"issue":"2","key":"10.1016\/j.abb.2016.02.010_bib27","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/0006-291X(92)90649-6","article-title":"Mechanism of inhibition of cholinesterases by huperzine A","volume":"184","author":"Ashani","year":"1992","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.abb.2016.02.010_bib28","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.neuint.2015.07.018","article-title":"Plant alkaloids as drug leads for Alzheimer's disease","volume":"89","author":"Ng","year":"2015","journal-title":"Neurochem. Int."},{"issue":"3","key":"10.1016\/j.abb.2016.02.010_bib29","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.pbb.2009.10.011","article-title":"Systemic administration of the potential countermeasure huperzine reversibly inhibits central and peripheral acetylcholinesterase activity without adverse cognitive-behavioral effects","volume":"94","author":"Myers","year":"2010","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"1","key":"10.1016\/j.abb.2016.02.010_bib30","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.cbi.2012.10.016","article-title":"A\u00a0combination of [+] and [-]-Huperzine A improves protection against soman toxicity compared to [+]-Huperzine A in guinea pigs","volume":"203","author":"Wang","year":"2013","journal-title":"Chem. Biol. Interact."},{"issue":"34","key":"10.1016\/j.abb.2016.02.010_bib31","doi-asserted-by":"crossref","first-page":"19694","DOI":"10.1074\/jbc.270.34.19694","article-title":"Fasciculin 2 binds to the peripheral site on acetylcholinesterase and inhibits substrate hydrolysis by slowing a step involving proton transfer during enzyme acylation","volume":"270","author":"Eastman","year":"1995","journal-title":"J.\u00a0Biol. Chem."},{"issue":"1","key":"10.1016\/j.abb.2016.02.010_bib32","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0167-4838(02)00285-6","article-title":"Multi-step analysis as a tool for kinetic parameter estimation and mechanism discrimination in the reaction between tight-binding fasciculin 2 and electric eel acetylcholinesterase","volume":"1597","author":"Goli\u010dnik","year":"2002","journal-title":"Biochim. Biophys. Acta"},{"issue":"15","key":"10.1016\/j.abb.2016.02.010_bib33","doi-asserted-by":"crossref","first-page":"11233","DOI":"10.1016\/S0021-9258(19)78115-0","article-title":"Site of fasciculin interaction with acetylcholinesterase","volume":"269","author":"Radi\u010d","year":"1994","journal-title":"J.\u00a0Biol. Chem."},{"issue":"1","key":"10.1016\/j.abb.2016.02.010_bib34","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/0167-4838(91)90029-Y","article-title":"On the inhibition of cholinesterase by D-tubocurarine","volume":"1079","author":"Stojan","year":"1991","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.abb.2016.02.010_bib35","unstructured":"Kharlamova AD, Lushchekina SV, Petrov KA, Kots ED, Nachon F, Villard-Wandhammer M, et\u00a0al. Slow-binding inhibition of acetylcholinesterase by an alkylammonium derivative of 6-methyluracil: mechanism and possible advantages for myasthenia gravis treatment. submitted."},{"issue":"40","key":"10.1016\/j.abb.2016.02.010_bib36","doi-asserted-by":"crossref","first-page":"9513","DOI":"10.1021\/ja971226d","article-title":"Molecular dynamics of acetylcholinesterase dimer complexed with tacrine","volume":"119","author":"Wlodek","year":"1997","journal-title":"J.\u00a0Am. Chem. Soc."},{"issue":"11","key":"10.1016\/j.abb.2016.02.010_bib37","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1002\/cmdc.201500334","article-title":"6-methyluracil derivatives as bifunctional acetylcholinesterase inhibitors for the treatment of Alzheimer's disease","volume":"10","author":"Semenov","year":"2015","journal-title":"ChemMedChem"},{"issue":"6","key":"10.1016\/j.abb.2016.02.010_bib38","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1002\/1521-3757(20020315)114:6<1095::AID-ANGE1095>3.0.CO;2-3","article-title":"Click chemistry in situ: acetylcholinesterase as a reaction vessel for the selective assembly of a femtomolar inhibitor from an array of building blocks","volume":"114","author":"Lewis","year":"2002","journal-title":"Angew. Chem."},{"issue":"40","key":"10.1016\/j.abb.2016.02.010_bib39","doi-asserted-by":"crossref","first-page":"12809","DOI":"10.1021\/ja046382g","article-title":"In situ click chemistry: enzyme inhibitors made to their own specifications","volume":"126","author":"Manetsch","year":"2004","journal-title":"J.\u00a0Am. Chem. Soc."},{"issue":"6","key":"10.1016\/j.abb.2016.02.010_bib40","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1073\/pnas.0308206100","article-title":"Freeze-frame inhibitor captures acetylcholinesterase in a unique conformation","volume":"101","author":"Bourne","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"18","key":"10.1016\/j.abb.2016.02.010_bib41","doi-asserted-by":"crossref","first-page":"6686","DOI":"10.1021\/ja043031t","article-title":"In situ selection of lead compounds by click chemistry: target-guided optimization of acetylcholinesterase inhibitors","volume":"127","author":"Krasinski","year":"2005","journal-title":"J.\u00a0Am. Chem. Soc."},{"issue":"9","key":"10.1016\/j.abb.2016.02.010_bib42","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1016\/j.bbapap.2006.07.008","article-title":"Mutant of Bungarus fasciatus acetylcholinesterase with low affinity and low hydrolase activity toward organophosphorus esters","volume":"1764","author":"Poyot","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"issue":"3","key":"10.1016\/j.abb.2016.02.010_bib43","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/cbdv.200800334","article-title":"3-Fluoro-2,4-dioxa-3-phosphadecalins as inhibitors of acetylcholinesterase. A reappraisal of kinetic mechanisms and diagnostic methods","volume":"6","author":"Baici","year":"2009","journal-title":"Chem. Biodivers."},{"issue":"2","key":"10.1016\/j.abb.2016.02.010_bib44","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/0005-2744(79)90122-0","article-title":"Fluorinated aldehydes and ketones acting as quasi-substrate inhibitors of acetylcholinesterase","volume":"567","author":"Brodbeck","year":"1979","journal-title":"Biochim. Biophys. Acta (BBA) Enzym."},{"issue":"21","key":"10.1016\/j.abb.2016.02.010_bib45","doi-asserted-by":"crossref","first-page":"8466","DOI":"10.1021\/bi00447a029","article-title":"Inhibition kinetics of acetylcholinesterase with fluoromethyl ketones","volume":"28","author":"Allen","year":"1989","journal-title":"Biochemistry"},{"issue":"22","key":"10.1016\/j.abb.2016.02.010_bib46","doi-asserted-by":"crossref","first-page":"9939","DOI":"10.1021\/ja00075a009","article-title":"m-(N, N,N-Trimethylammonio)trifluoroacetophenone: a femtomolar inhibitor of acetylcholinesterase","volume":"115","author":"Nair","year":"1993","journal-title":"J.\u00a0Am. Chem. Soc."},{"issue":"28","key":"10.1016\/j.abb.2016.02.010_bib47","doi-asserted-by":"crossref","first-page":"8566","DOI":"10.1021\/bi00194a023","article-title":"Molecular recognition in acetylcholinesterase catalysis: free-energy correlations for substrate turnover and inhibition by trifluoro ketone transition-state analogs","volume":"33","author":"Nair","year":"1994","journal-title":"Biochemistry"},{"issue":"10","key":"10.1016\/j.abb.2016.02.010_bib48","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1021\/ja952232h","article-title":"The X-ray structure of a transition state analog complex reveals the molecular origins of the catalytic power and substrate specificity of acetylcholinesterase","volume":"118","author":"Harel","year":"1996","journal-title":"J.\u00a0Am. Chem. Soc."},{"issue":"10","key":"10.1016\/j.abb.2016.02.010_bib49","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1134\/S0006297912100070","article-title":"Time-dependent kinetic complexities in cholinesterase-catalyzed reactions","volume":"77","author":"Masson","year":"2012","journal-title":"Biochem. Mosc."},{"issue":"8","key":"10.1016\/j.abb.2016.02.010_bib50","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/cbic.200300571","article-title":"Photoreversible inhibition of cholinesterases: catalytic serine-labeled caged butyrylcholinesterase","volume":"4","author":"Loudwig","year":"2003","journal-title":"ChemBioChem"},{"issue":"6","key":"10.1016\/j.abb.2016.02.010_bib51","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1021\/tx100447k","article-title":"Reaction of cresyl saligenin phosphate, the organophosphorus implicated in the aerotoxic syndrome, with human cholinesterases: mechanistic studies employing kinetics, mass spectrometry and X-ray structure analysis","volume":"24","author":"Carletti","year":"2011","journal-title":"Chem. Res. Toxicol."},{"issue":"2","key":"10.1016\/j.abb.2016.02.010_bib52","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1021\/tx3004505","article-title":"Inhibition pathways of the potent organophosphate CBDP with cholinesterases revealed by X-ray crystallographic snapshots and mass spectrometry","volume":"26","author":"Carletti","year":"2013","journal-title":"Chem. Res. Toxicol."},{"issue":"11","key":"10.1016\/j.abb.2016.02.010_bib53","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1007\/s11172-013-0366-9","article-title":"Molecular modeling of butyrylcholinesterase inhibition by cresyl saligenin phosphate","volume":"62","author":"Lushchekina","year":"2013","journal-title":"Russ. Chem. Bull."},{"issue":"3","key":"10.1016\/j.abb.2016.02.010_bib54","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1042\/BJ20130389","article-title":"Effects of viscosity and osmotic stress on the reaction of human butyrylcholinesterase with cresyl saligenin phosphate, a toxicant related to the aerotoxic syndrome: kinetic and molecular dynamics studies","volume":"454","author":"Masson","year":"2013","journal-title":"Biochem. J."},{"key":"10.1016\/j.abb.2016.02.010_bib55","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1007\/s12031-013-0178-2","article-title":"Molecular modeling evidence for His 438 flip in the mechanism of BuChE hysteretic behavior","volume":"52","author":"Lushchekina","year":"2014","journal-title":"J.\u00a0Mol. Neurosci."},{"issue":"1","key":"10.1016\/j.abb.2016.02.010_bib56","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0167-4838(97)00133-7","article-title":"Long chain analogs of physostigmine as potential drugs for Alzheimer's disease: new insights into the mechanism of action in the inhibition of acetylcholinesterase","volume":"1343","author":"Perola","year":"1997","journal-title":"Biochim. Biophys. Acta"},{"issue":"2","key":"10.1016\/j.abb.2016.02.010_bib57","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1093\/toxsci\/kfj094","article-title":"Concentration-dependent kinetics of acetylcholinesterase inhibition by the organophosphate paraoxon","volume":"90","author":"Rosenfeld","year":"2006","journal-title":"Toxicol. Sci."},{"issue":"2","key":"10.1016\/j.abb.2016.02.010_bib58","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.taap.2009.08.014","article-title":"An evaluation of the inhibition of human butyrylcholinesterase and acetylcholinesterase by the organophosphate chlorpyrifos oxon","volume":"241","author":"Shenouda","year":"2009","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"4","key":"10.1016\/j.abb.2016.02.010_bib59","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1016\/S0006-3495(98)77610-6","article-title":"Analysis of synaptic transmission in the neuromuscular junction using a continuum finite element model","volume":"75","author":"Smart","year":"1998","journal-title":"Biophys. J."},{"issue":"9\u201310","key":"10.1016\/j.abb.2016.02.010_bib60","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.mcm.2006.03.003","article-title":"Spatio-temporal concentration of acetylcholine in vertebrate synaptic cleft","volume":"44","author":"Aidoo","year":"2006","journal-title":"Math. Comput. Model."},{"issue":"5","key":"10.1016\/j.abb.2016.02.010_bib61","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1002\/bies.200900167","article-title":"The biological significance of substrate inhibition: a mechanism with diverse functions","volume":"32","author":"Reed","year":"2010","journal-title":"BioEssays"},{"key":"10.1016\/j.abb.2016.02.010_bib62","series-title":"Contemporary High Performance Computing: from Petascale toward Exascale","first-page":"283","article-title":"\u201cLomonosov\u201d: supercomputing at Moscow State University","author":"Sadovnichy","year":"2013"}],"container-title":["Archives of Biochemistry and Biophysics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003986116300297?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003986116300297?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T11:04:59Z","timestamp":1748775899000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003986116300297"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":62,"alternative-id":["S0003986116300297"],"URL":"https:\/\/doi.org\/10.1016\/j.abb.2016.02.010","relation":{},"ISSN":["0003-9861"],"issn-type":[{"value":"0003-9861","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Slow-binding inhibition of cholinesterases, pharmacological and toxicological relevance","name":"articletitle","label":"Article Title"},{"value":"Archives of Biochemistry and Biophysics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.abb.2016.02.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}